Recent advances of bispecific antibodies in solid tumors.

Recent advances of bispecific antibodies in solid tumors.

Item
http://www.wikidata.org/entity/Q41696278
Development and clinical application of anti-HER2 monoclonal and bispecific antibodies for cancer treatment.Novel agents for pancreatic ductal adenocarcinoma: emerging therapeutics and future directions.Bispecific antibodies: design, therapy, perspectives.EGFR-TKIs resistance via EGFR-independent signaling pathways.Tribody [(HER2)2xCD16] Is More Effective Than Trastuzumab in Enhancing γδ T Cell and Natural Killer Cell Cytotoxicity Against HER2-Expressing Cancer Cells.Gut microbiome modulates efficacy of immune checkpoint inhibitors.Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer.Bispecific antibodies in cancer immunotherapyEmerging Therapies in the Management of Advanced-Stage Gastric CancerBi-specific and tri-specific antibodies- the next big thing in solid tumor therapeuticsCytokine release syndrome: grading, modeling, and new therapyOrganoid technology and applications in cancer research
P2860

Recent advances of bispecific antibodies in solid tumors.

Item
http://www.wikidata.org/entity/Q41696278
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Recent advances of bispecific antibodies in solid tumors.
@en
type
label
Recent advances of bispecific antibodies in solid tumors.
@en
prefLabel
Recent advances of bispecific antibodies in solid tumors.
@en
P1433
P1476
P2093
P275
P2860
P2888
P304
P31
P356
P433
P478
P5008
P577
P6179
P698
P921
P932
P356
P1433
P1476
Recent advances of bispecific antibodies in solid tumors.
@en
P2093
P275
P2860
P2888
P304
P31
P356
P433
P478
P5008
P577
P6179
P698
P921
P932